{"transactions":[{"id":1027461,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":123,"price":47.0133,"value":5782.6359,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $47.00 to $47.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":764127,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027460,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":177,"price":47.0133,"value":8321.3541,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $47.00 to $47.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1050599,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027459,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":57502,"price":46.4068,"value":2668483.8136,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $46.00 to $46.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":764250,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027458,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":83066,"price":46.4068,"value":3854827.2488,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $46.00 to $46.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1050776,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027457,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":34405,"price":45.3547,"value":1560428.4535,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $45.00 to $45.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":821752,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027456,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":49701,"price":45.3547,"value":2254173.9447,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $45.00 to $45.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1133842,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1034668,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":132,"price":43.3,"value":5715.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":856157,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034667,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":268,"price":43.3,"value":11604.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1183543,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034666,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":20148,"price":43.0038,"value":866440.5624,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $42.25 to $43.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":856289,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034665,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":40907,"price":43.0038,"value":1759156.4466,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $42.25 to $43.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1183811,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034664,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":24370,"price":41.5908,"value":1013567.796,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $41.25 to $42.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":876437,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034663,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":49479,"price":41.5908,"value":2057871.1932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $41.25 to $42.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1224718,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1055814,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":1707,"price":39.5022,"value":67430.2554,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.49 to $39.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (8) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":900807,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055813,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":3465,"price":39.5022,"value":136875.123,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.49 to $39.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (8) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1274197,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055812,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":21661,"price":38.9744,"value":844224.4784,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.50 to $39.485, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (7) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":902514,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055811,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":43978,"price":38.9744,"value":1714016.1632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.50 to $39.485, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (7) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1277662,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055810,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":1058,"price":39.9212,"value":42236.6296,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.81 to $40.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":924175,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055809,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":2149,"price":39.9212,"value":85790.6588,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.81 to $40.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1321640,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055808,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":24760,"price":39.5255,"value":978651.38,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.815 to $39.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":925233,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055807,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":50270,"price":39.5255,"value":1986946.885,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.815 to $39.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1323789,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055806,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":2809,"price":40.5899,"value":114017.0291,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $40.50 to $40.8819, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":949993,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055805,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":5668,"price":40.5899,"value":230063.5532,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $40.50 to $40.8819, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1374059,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055804,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":10076,"price":40.0297,"value":403339.2572,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.5085 to $40.4616, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":952802,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055803,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":20493,"price":40.0297,"value":820328.6421,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.5085 to $40.4616, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1379727,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1061958,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:51:33.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":15085,"price":38.5611,"value":581694.1935,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.26 to $39.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":962878,"source":{"system":"sec-edgar","filing":"0000950170-25-110163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025110163/ownership.xml","form_type":"4"}},{"id":1061957,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:51:33.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":30628,"price":38.5611,"value":1181049.3708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.26 to $39.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1400220,"source":{"system":"sec-edgar","filing":"0000950170-25-110163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025110163/ownership.xml","form_type":"4"}},{"id":1061956,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:51:33.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":69949,"price":39.5,"value":2762985.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":977963,"source":{"system":"sec-edgar","filing":"0000950170-25-110163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025110163/ownership.xml","form_type":"4"}},{"id":1061955,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:51:33.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":145051,"price":39.5,"value":5729514.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1430848,"source":{"system":"sec-edgar","filing":"0000950170-25-110163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025110163/ownership.xml","form_type":"4"}},{"id":1068949,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":274990,"ownership":{"direct":false,"nature":"By Versant Vantage II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage II, L.P. (\"Vantage II\"). Versant Vantage II GP, L.P. (\"Vantage II GP\") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (\"Vantage II GP-GP\") is the sole general partner of Vantage II GP. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Vantage II GP-GP. Each of Vantage II GP-GP, Vantage II GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Vantage II, and each disclaims beneficial ownership of the shares held by Canada V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1068948,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":82006,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Affiliates V, and each disclaims beneficial ownership of the shares held by Affiliates, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1068947,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":90888,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Ophthalmic, and each disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1068946,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":207486,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Dr. Davis, a member of the Issuer's board of directors, is a director of Canada V GP-GP. Each of Canada V GP-GP, Canada V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Canada V, and each disclaims beneficial ownership of the shares held by Canada V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1068945,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":2726322,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis (\"Dr. Davis\"), a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Versant V, and each disclaims beneficial ownership of the shares held by Versant V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1088074,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-14T20:50:19.000Z","date":"2025-07-10","kind":"sale","planned":false,"acquired":false,"shares":191376,"price":34,"value":6506784.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1575899,"source":{"system":"sec-edgar","filing":"0000950170-25-095616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025095616/ownership.xml","form_type":"4"}},{"id":1097972,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-01T22:16:12.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":30.465,"value":6093000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $30.18 to $30.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1767275,"source":{"system":"sec-edgar","filing":"0000950170-25-092373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025092373/ownership.xml","form_type":"4"}},{"id":1105091,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:50:38.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":133924,"price":30.25,"value":4051201.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC\nVI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary\ninterests therein."}],"balance_after":1967275,"source":{"system":"sec-edgar","filing":"0000950170-25-088604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025088604/ownership.xml","form_type":"4"}},{"id":1105090,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:50:38.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":100877,"price":30.35,"value":3061616.95,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1047912,"source":{"system":"sec-edgar","filing":"0000950170-25-088604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025088604/ownership.xml","form_type":"4"}},{"id":1105089,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:50:38.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":29.95,"value":2995000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1148789,"source":{"system":"sec-edgar","filing":"0000950170-25-088604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025088604/ownership.xml","form_type":"4"}},{"id":1113608,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:37:21.000Z","date":"2025-06-10","kind":"sale","planned":false,"acquired":false,"shares":350000,"price":29,"value":10150000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1248789,"source":{"system":"sec-edgar","filing":"0000950170-25-085490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025085490/ownership.xml","form_type":"4"}},{"id":1436058,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-12T20:33:19.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":387999,"price":1.1005,"value":426992.8995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.10 to $1.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":209941,"source":{"system":"sec-edgar","filing":"0000950170-24-095675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777652/000095017024095675/ownership.xml","form_type":"4"}},{"id":1436057,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-12T20:33:19.000Z","date":"2024-08-08","kind":"sale","planned":false,"acquired":false,"shares":400000,"price":1.3501,"value":540040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.35 to $1.375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":597940,"source":{"system":"sec-edgar","filing":"0000950170-24-095675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777652/000095017024095675/ownership.xml","form_type":"4"}},{"id":1561958,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-25T20:30:48.000Z","date":"2024-03-21","kind":"other","planned":false,"acquired":true,"shares":598203,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to that certain Agreement and Plan of Merger by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer (\"Merger Sub\"), and Lenz Therapeutics, Inc., a Delaware corporation (\"LENZ\"), pursuant to which the Merger Sub merged with and into LENZ (the \"Merger\"), with LENZ continuing as a wholly owned subsidiary of the Issuer and the surviving corporation of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to that certain Agreement and Plan of Merger by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer (\"Merger Sub\"), and Lenz Therapeutics, Inc., a Delaware corporation (\"LENZ\"), pursuant to which the Merger Sub merged with and into LENZ (the \"Merger\"), with LENZ continuing as a wholly owned subsidiary of the Issuer and the surviving corporation of the Merger."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective March 21, 2024, prior to the closing of the Merger, the Issuer effected a one-for-seven reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Vantage II, L.P. (\"VV II\"). Versant Vantage II GP-GP, LLC (\"VV II GP-GP\") is the sole general partner of Versant Vantage II GP, L.P. (\"VV II GP\") and VV II GP is the sole general partner of VV II. Each of VV II GP-GP and VV II GP disclaims beneficial ownership of the shares held by VV II, except to the extent of their respective pecuniary interests therein."}],"balance_after":842162,"source":{"system":"sec-edgar","filing":"0000950170-24-035951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017024035951/ownership.xml","form_type":"4"}},{"id":1822198,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":2196402,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Vantage II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage II, L.P. (\"Vantage II\"). Versant Vantage II GP, L.P. (\"Vantage II GP\") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP\") is the sole general partner of Vantage II GP. Jerel C. Davis is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":274990},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822197,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":33682,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4216},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822196,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":37283,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4667},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822195,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":85217,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10669},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822194,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":1119729,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":140190},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822193,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":230117,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28810},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822192,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":255081,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31936},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822191,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":582206,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":72892},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822190,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":7650043,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":957787},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822189,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":106208,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13297},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822188,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":117730,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14739},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822187,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":268711,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33642},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822186,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":3530789,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":442055},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822185,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":237575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29744},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822184,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":263349,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":32971},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822183,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":601077,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":75255},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822182,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":7897999,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":988832},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822181,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":5939,"price":12,"value":71268.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":82006,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822180,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":6575,"price":12,"value":78900.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":90888,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822179,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":15028,"price":12,"value":180336.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":207486,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822178,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":197458,"price":12,"value":2369496.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2726322,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822177,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":274990,"ownership":{"direct":false,"nature":"By Versant Vantage II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage II, L.P. (\"Vantage II\"). Versant Vantage II GP, L.P. (\"Vantage II GP\") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP\") is the sole general partner of Vantage II GP. Jerel C. Davis is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":274990,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822176,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":76067,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":76067,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822175,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":84313,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":84313,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822174,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":192458,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":192458,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822173,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":2528864,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2528864,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":2188261,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:55:48.000Z","date":"2022-08-09","kind":"other","acquired":false,"shares":364800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant VI to its limited partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reportable securities are owned directly by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":11452014,"source":{"system":"sec-edgar","filing":"0000899243-22-028388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000089924322028388/doc4.xml","form_type":"4"}},{"id":2188260,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:55:48.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":550000,"price":13.0302,"value":7166610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by Versant Venture Capital VI, L.P. (\"Versant VI\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $13.03 to $13.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reportable securities are owned directly by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":11816814,"source":{"system":"sec-edgar","filing":"0000899243-22-028388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000089924322028388/doc4.xml","form_type":"4"}},{"id":2417029,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-02T21:31:43.000Z","date":"2022-01-31","kind":"other","acquired":false,"shares":178996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"Versant VI\") to its limited partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reportable securities are owned directly by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":12366814,"source":{"system":"sec-edgar","filing":"0000899243-22-004169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000089924322004169/doc4.xml","form_type":"4"}},{"id":2457970,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T21:46:48.000Z","date":"2021-12-23","kind":"other","acquired":false,"shares":371004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"Versant VI\") to its limited partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reportable securities are owned directly by Versant VI. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":12545810,"source":{"system":"sec-edgar","filing":"0000899243-21-049938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000089924321049938/doc4.xml","form_type":"4"}},{"id":2648014,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-07-01T23:01:08.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":3715415,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"These shares of the Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of the Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These shares of the Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These shares of the Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by Versant Vantage II, L.P. (\"VV II\"). Versant Vantage II GP-GP, LLC (\"VV II GP-GP\") is the sole general partner of Versant Vantage II GP, L.P. (\"VV II GP\") and VV II GP is the sole general partner of VV II. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV II GP-GP and may be deemed to share voting and dispositive power over the shares held by VV II. Each of VV II GP-GP, VV II GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV II, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1527719},"source":{"system":"sec-edgar","filing":"0000899243-21-027018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027018/doc4.xml","form_type":"4"}},{"id":2648013,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-07-01T23:01:08.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":30019945,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of the Series A Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of the Series A Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of the Series A Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of the Series A Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series A Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12343727},"source":{"system":"sec-edgar","filing":"0000899243-21-027018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027018/doc4.xml","form_type":"4"}},{"id":2648012,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T23:01:08.000Z","date":"2021-06-29","kind":"purchase","acquired":true,"shares":180000,"price":17,"value":3060000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by Versant Vantage II, L.P. (\"VV II\"). Versant Vantage II GP-GP, LLC (\"VV II GP-GP\") is the sole general partner of Versant Vantage II GP, L.P. (\"VV II GP\") and VV II GP is the sole general partner of VV II. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV II GP-GP and may be deemed to share voting and dispositive power over the shares held by VV II. Each of VV II GP-GP, VV II GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV II, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1707719,"source":{"system":"sec-edgar","filing":"0000899243-21-027018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027018/doc4.xml","form_type":"4"}},{"id":2648011,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T23:01:08.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":1527719,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of the Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by Versant Vantage II, L.P. (\"VV II\"). Versant Vantage II GP-GP, LLC (\"VV II GP-GP\") is the sole general partner of Versant Vantage II GP, L.P. (\"VV II GP\") and VV II GP is the sole general partner of VV II. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV II GP-GP and may be deemed to share voting and dispositive power over the shares held by VV II. Each of VV II GP-GP, VV II GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV II, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1527719,"source":{"system":"sec-edgar","filing":"0000899243-21-027018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027018/doc4.xml","form_type":"4"}},{"id":2648010,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T23:01:08.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":12343727,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of the Series A Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series A Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":14708398,"source":{"system":"sec-edgar","filing":"0000899243-21-027018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027018/doc4.xml","form_type":"4"}},{"id":2657583,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-06-23T20:30:28.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":1545125,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned by Versant Vantage II, L.P. (\"Versant Vantage II''). Versant Vantage II GP, L.P. (\"Versant Vantage II GP\") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC (\"Versant Vantage II GP-GP\") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":614095},"source":{"system":"sec-edgar","filing":"0001104659-21-084643","document":"tm2120529-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465921084643/tm2120529-1_4seq1.xml","form_type":"4"}},{"id":2657582,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-06-23T20:30:28.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":25000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reportable securities are owned directly by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their  pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9936011},"source":{"system":"sec-edgar","filing":"0001104659-21-084643","document":"tm2120529-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465921084643/tm2120529-1_4seq1.xml","form_type":"4"}},{"id":2657581,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T20:30:28.000Z","date":"2021-06-22","kind":"purchase","acquired":true,"shares":100000,"price":20,"value":2000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned by Versant Vantage II, L.P. (\"Versant Vantage II''). Versant Vantage II GP, L.P. (\"Versant Vantage II GP\") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC (\"Versant Vantage II GP-GP\") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":714095,"source":{"system":"sec-edgar","filing":"0001104659-21-084643","document":"tm2120529-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465921084643/tm2120529-1_4seq1.xml","form_type":"4"}},{"id":2657580,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T20:30:28.000Z","date":"2021-06-22","kind":"exercise","acquired":true,"shares":614095,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned by Versant Vantage II, L.P. (\"Versant Vantage II''). Versant Vantage II GP, L.P. (\"Versant Vantage II GP\") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC (\"Versant Vantage II GP-GP\") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein."}],"balance_after":614095,"source":{"system":"sec-edgar","filing":"0001104659-21-084643","document":"tm2120529-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465921084643/tm2120529-1_4seq1.xml","form_type":"4"}},{"id":2657579,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T20:30:28.000Z","date":"2021-06-22","kind":"exercise","acquired":true,"shares":9936011,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reportable securities are owned directly by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their  pecuniary interest therein."}],"balance_after":12916814,"source":{"system":"sec-edgar","filing":"0001104659-21-084643","document":"tm2120529-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465921084643/tm2120529-1_4seq1.xml","form_type":"4"}}]}